Exascale Labs Holdings Inc.
XLAB Nasdaq· Services-Prepackaged Software
Last close · Oct 26, 2026
$3.39
KIRA · Stoqly’s AI analyst, in plain words
- Exascale Labs Holdings Inc. had $14.8M of revenue in fiscal 2026, up 111.3% on the year before.
- Its operating margin was −32.4%, up 11.0 pts: of every 100 in sales, about −32 is left after running the business.
- Exascale Labs Holdings Inc. lost $12.2M in fiscal 2026.
Market cap
$0.0M
P/E
—
Revenue
$14.8M
Net income
−$12.2M
Free cash flow
—
Operating margin
−32.4%
Exascale Labs Holdings Inc. in 30 seconds · fiscal 2026
Are sales growing?
+111.3%
Yes. Sales grew 111.3% last year.
Does it make a profit?
−82.1%
No. It lost money last year.
How healthy are the accounts?
4 / 8
Mixed. It passes 4 of 8 health tests.
How is the share priced?
—
No P/E: it made no profit over the last four quarters.
What Exascale Labs Holdings Inc. does
No business description yet.
- Fiscal year ends
- June 30, 2026
- Latest annual report
- 10-K · Sep 28, 2026
- Legal name
- Exascale Labs Holdings Inc.
- CIK
- 0002109869
Exascale Labs Holdings Inc. · XLAB
Results and finances
The last 2 fiscal years. Amounts in USD.
| Fiscal year | FY25 | FY26 |
|---|---|---|
| Sales and profit | ||
| Revenue | $7.0M | $14.8M |
| Revenue growth | — | 111.3% |
| Gross margin | 15.8% | 16.3% |
| Operating margin | −43.4% | −32.4% |
| Net income | −$7.7M | −$12.2M |
| Net margin | −109.2% | −82.1% |
| Diluted EPS | −$5,106.44 | −$8,108.26 |
| Cash | ||
| Cash from operations | −$1.0M | −$2.8M |
| Capital expenditure | $0.0M | — |
| Free cash flow | −$1.0M | — |
| FCF margin | −14.4% | — |
| Share count change | — | 0.0% |
| Debt and strength | ||
| Cash and short-term investments | $4.2M | $2.7M |
| Shareholders' equity | −$13.0M | −$25.2M |
| Current ratio | 0.4x | 0.2x |
| Returns and quality | ||
| Piotroski F-score | — | 4 |
| Altman Z'' | −21.0 | −42.7 |
Insiders bought, 12 months
$0.0M
0 insiders
Insiders sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
How to read these numbers
- Revenue:
- Total sales reported in the income statement.
- Operating margin:
- Operating income as a share of revenue.
- Net income:
- Profit after all expenses, interest and tax.
- Free cash flow:
- Cash from operations minus capital spending.
- Net debt / EBITDA:
- Years of EBITDA needed to pay off net debt. Below zero means more cash than debt.
- Return on capital:
- After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Exascale Labs Holdings Inc. · XLAB
Charts and comparison
Ten years at a glance, and how it stacks up against similar companies.
Revenue
Net income
Margins, % of revenue
Cash vs debt (incl. leases)
Free cash flow
Dividends and buybacks
KIRA
At $3.39 a share, the company is worth $0.0M.
Source: SEC EDGAR XBRL filings (CIK 0002109869). Data updated October 24, 2026. For information only — not investment advice. Check the original filings before relying on any figure.